A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Public ClinicalTrials.gov record NCT07170150. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease (MCI to Mild Dementia Due to AD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment \[MCI\] to mild dementia due to AD).
Study identification
- NCT ID
- NCT07170150
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,060 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 12, 2025 (Actual)
- Primary completion
- Feb 16, 2028 (Estimated)
- Completion
- Feb 16, 2028 (Estimated)
- Last update posted
- Sep 25, 2026
2025 – 2028
United States locations
- U.S. sites
- 33
- U.S. states
- 17
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Alzheimer?s Institute | Phoenix | Arizona | 85006 | — |
| Sun Valley Research Center, Inc. | Imperial | California | 92251 | — |
| Healthy Brain Clinic | Long Beach | California | 90804 | — |
| Oakland Clinical | Oakland | California | 94609 | — |
| Riverside Clinical | Riverside | California | 92506 | — |
| Cenexel California Neuroscience Research, LLC | Sherman Oaks | California | 91403 | — |
| Yale University | New Haven | Connecticut | 06510 | — |
| JEM Research LLC | Atlantis | Florida | 33462 | — |
| K2 Medical Research-Winter Garden | Clermont | Florida | 34711 | — |
| Visionary Investigators Network- Neurology Aventura | Miami | Florida | 33133 | — |
| Charter Research - Winter Park/Orlando | Orlando | Florida | 32803 | — |
| Conquest Research - Lake Nona | Orlando | Florida | 32832 | — |
| Alzheimer's Research and Treatment Center | Stuart | Florida | 34996 | — |
| CenExel iResearch, LLC | Decatur | Georgia | 30030 | — |
| Center for Advanced Research & Education | Gainesville | Georgia | 30501 | — |
| Great Lakes Clinical Trials Chicago d/b/a Flourish Research Andersonville | Chicago | Illinois | 60640 | — |
| Adams Clinical Boston | Boston | Massachusetts | 02116 | — |
| Adams Clinical Watertown | Watertown | Massachusetts | 02472 | — |
| Quest Research Institute | Farmington Hills | Michigan | 48334 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198-8440 | — |
| The Cognitive and Research Center of New Jersey | Springfield | New Jersey | 07081 | — |
| IMA Clinical Research - Albuquerque | Albuquerque | New Mexico | 87109 | — |
| AD-CARE, University of Rochester Medical Center | Rochester | New York | 14620 | — |
| Summit Research Network Inc. | Portland | Oregon | 97210 | — |
| Flourish Research ? Philadelphia | Plymouth Meeting | Pennsylvania | 19462 | — |
| Palmetto Clinical Trials | Summerville | South Carolina | 29485 | — |
| Gadolin Research, LLC | Beaumont | Texas | 77702 | — |
| Kerwin Medical Center | Dallas | Texas | 75216 | — |
| Re:Cognition Health - Fort Worth | Fort Worth | Texas | 76104 | — |
| Mt.Olympus Medical Research | Katy | Texas | 77450 | — |
| El Faro Health and Therapeutics | Rio Grande City | Texas | 78582 | — |
| Sana Research, LLC | Arlington | Virginia | 22205 | — |
| Re:Cognition Health | Fairfax | Virginia | 22031 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 114 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07170150, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 25, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07170150 live on ClinicalTrials.gov.